Vaccine produces long-lasting anti-tumor response in patients with melanoma
E-Mail BOSTON - Four years after patients with melanoma were treated with a personalized cancer vaccine, the immune response kindled by the vaccine remains robust and effective in keeping cancer cells under control, researchers at Dana-Farber Cancer Institute, Brigham and Womens Hospital, and the Broad Institute of MIT and Harvard report in a new study. The findings, published online today by the journal Nature Medicine, demonstrate the staying power of the immune response generated by the v...
United States Massachusetts Institute Of Technology Dana Farber Cancer Institute City Of United Kingdom Pavan Bachireddy
Source: eurekalert.org